Literature DB >> 16458143

Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.

Pilar Herrero1, Linda R Peterson, Janet B McGill, Stanley Matthew, Donna Lesniak, Carmen Dence, Robert J Gropler.   

Abstract

OBJECTIVES: The purpose of this study was to determine if myocardial fatty acid utilization (MFAU) and myocardial fatty acid oxidation (MFAO) are increased in diabetic patients.
BACKGROUND: Experimental models of diabetes mellitus demonstrate that MFAU and MFAO are increased, and that this dependence on myocardial fatty acid metabolism may be detrimental to cardiac function. Whether similar metabolic changes occur in humans with diabetes mellitus is unclear.
METHODS: Eleven healthy non-diabetic control patients (5 women, ages 25 +/- 5 years) and 11 otherwise healthy patients with type 1 diabetes mellitus (T1DM) (8 women, ages 36 +/- 10 years, HbA1c 8.4 +/- 1.9%) underwent positron emission tomography for the determination of myocardial blood flow (MBF); myocardial oxygen consumption (MVO2); myocardial glucose utilization (MGU); and MFAU, MFAO, and %MFAO.
RESULTS: Plasma lactate, insulin, and MBF levels were similar between the two groups. However, plasma glucose (5.71 +/- 0.98 mumol/ml vs. 5.28 +/- 0.65 mumol/ml, p = 0.04), free fatty acid levels (0.60 +/- 0.24 mumol/ml vs. 0.19 +/- 0.07 mumol/ml, p < 0.0001), and MVO2 (6.64 +/- 2.21 vs. 4.51 +/- 1.39 mumol/g/min, p = 0.007) levels were higher in the T1DM subjects. Furthermore, compared with control patients, T1DM subjects exhibited higher MFAU (213 +/- 135 nmol/g/min vs. 57 +/- 28 nmol/g/min, p = 0.0004), MFAO (206 +/- 131 nmol/g/min s. 50 +/- 26 nmol/g/min, p = 0.0002), and %MFAO (94 +/- 6% vs. 81 +/- 19%, respectively, p = 0.04). In contrast, MGU was lower in T1DM subjects than in controls (207 +/- 108 nmol/g/min vs. 403 +/- 191 nmol/g/min, p = 0.0008).
CONCLUSIONS: Humans with diabetes mellitus exhibit increased MFAU and MFAO and reduced MGU consistent with observations obtained in experimental models of diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458143     DOI: 10.1016/j.jacc.2005.09.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  80 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

2.  Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.

Authors:  Zhude Tu; Shihong Li; Terry L Sharp; Pilar Herrero; Carmen S Dence; Robert J Gropler; Robert H Mach
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

3.  Sex differences in myocardial oxygen and glucose metabolism.

Authors:  Linda R Peterson; Pablo F Soto; Pilar Herrero; Kenneth B Schechtman; Carmen Dence; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2007-06-27       Impact factor: 5.952

Review 4.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 5.  Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes.

Authors:  Jennifer G Duncan
Journal:  Pediatr Cardiol       Date:  2011-02-02       Impact factor: 1.655

Review 6.  Imaging of myocardial fatty acid metabolism with PET.

Authors:  Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 7.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

8.  Exercise training impacts the myocardial metabolism of older individuals in a gender-specific manner.

Authors:  Pablo F Soto; Pilar Herrero; Kenneth B Schechtman; Alan D Waggoner; Jeffrey M Baumstark; Ali A Ehsani; Robert J Gropler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

Review 9.  Nonischemic heart failure in diabetes mellitus.

Authors:  Ashrith Guha; Romain Harmancey; Heinrich Taegtmeyer
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

Review 10.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.